The end of effective antibiotics will be frightening. Life expectancy will fall dramatically and people of all ages will die from illnesses that we are used to treating with $10 worth of pills.
L’expertise universitaire, l’exigence journalistique
Articles sur Pharmaceutical companies
Affichage de 21 à 22 de 22 articles
Nevada plans to use a new drug protocol for executing Scott Dozier, who murdered a 22-year-old. A scholar explains why this is problematic.
Les contributeurs les plus fréquents
-
Joel Lexchin est un·e adhérent·e de The ConversationProfessor Emeritus of Health Policy and Management, York University, Canada
-
Professor of Philosophy, Binghamton University, State University of New York
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Professor of Biochemistry and Biomedical Sciences, McMaster University
-
Director of the Bioethics Program and affiliate faculty in Law and International Affairs, Penn State
-
Associate Professor & Chair of Eco-Entrepreneurship, McMaster University
-
Professor of Law, Indiana University
-
Dean of the College of Science, Professor of Biochemistry, Rochester Institute of Technology
-
Henry Baldwin Professorial Research Fellow in Health System Sustainability, University of Tasmania
-
Associate Professor of Aesthetics and Art Theory, Nanjing University
-
PhD Candidate and Pharmacist, University of Sydney
-
Adjunct Lecturer, School of Pharmacy, University of Sydney
-
Assistant Professor, Department of Family and Community Medicine, University of Toronto
-
Medical Director, Genea Fertility Melbourne; Clinical Associate Professor, Faculty of Medicine, Dentistry & Health Sciences, The University of Melbourne
